Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy

Leukemia and Lymphoma

Volumn 54, Issue 6, 2013, Pages 1183-1187

  Filippi, Andrea Riccardo ^a   Botticella, Angela ^a   Bellò, Marilena ^b   Botto, Barbara ^b   Castiglione, Anna ^b   Gavarotti, Paolo ^b   Gottardi, Daniela ^b   Parvis, Guido ^b   Bisi, Gianni ^b   Levis, Alessandro ^c   Vitolo, Umberto ^b   Ricardi, Umberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c C Arrigo Children's Hospital   (Italy)

Author keywords

Hodgkin lymphoma; Involved field radiotherapy; PET; Prognostic factors; Response adapted therapy

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; VINBLASTINE;

ADOLESCENT; ADULT; AGED; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877748925     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.735667     Document Type: Review

References (12)

1. Hutchings M, M ikhaeel N G, F ields P A, et a l. P rognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma . Ann Oncol 2005; 16: 1160- 1168.
2. Hutchings M, Loft A, Hansen M, et al . FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma . Blood 2006; 107: 52- 59.
3. G allamini A, H utchings M, R igacci L, et a l. E arly interim 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin ' s lymphoma: A report from a joint Italian-Danish study J Clin Oncol 2007; 25 : 3746 - 3752.
4. Cerci JJ, Pracchia LF, Linardi CC, et al . 18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma . J Nucl Med 2010; 51: 1337- 1343.
5. B arnes J A, L aCasce A S, Z ukotynski K, et a l. E nd-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin' s lymphoma . Ann Oncol 2011; 22: 910- 915.
6. Zinzani PL, Rigacci L, Stefoni V, et al . Early interim 18F-FDG PET in Hodgkin ' s lymphoma: Evaluation on 304 patients . Eur J Nucl Med Mol Imaging 2011; 39: 4- 12.
7. Lister TA, Crowther D, Sutcliffe SB, et al . Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin ' s disease: Cotswolds meeting . J Clin Oncol 1989; 7 : 1630 - 1636. Erratum in: J Clin Oncol 1990;8:1602.
8. Tubiana M, Henry AM, Carde P, et al . Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin ' s disease. The EORTC lymphoma group controlled clinical trials: 1964 - 1987 . Blood 1989; 73 : 47 - 56.
9. Yahalom J, Mauch P . The involved field is back: Issues in delineating the radiation field in Hodgkin' s disease . Ann Oncol 2002; 13(Suppl. 1): 79 - 83.
10. Meignan M, Gallamini A, Haioun C . Report on the First International Workshop on interim-PET-scan in lymphoma . Leuk Lymphoma 2009; 50: 1257- 1260.
11. Cheson BD, Pfi stner B, Juweid ME, et al . Revised response criteria for malignant lymphoma . J Clin Oncol 2007; 25 : 579 - 586.
12. Sher DJ, Mauch PM, Van Den Abbeele A, et al . Prognostic signifi cance of mid- and post-ABVD PET imaging in Hodgkin ' s lymphoma: The importance of involved-field radiotherapy . Ann Oncol 2009; 20 : 1848 - 1853.